Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.

Mats NågårdMei-Lin Ah-SeeJames StraussTrisha Wise-DraperHoward P SafranLaura NadeauWilliam J EdenfieldLionel D LewisDinko RekićCorina DotaLone H OttesenYan LiGanesh M Mugundu

Published in: Cancer chemotherapy and pharmacology (2023)

GOV: NCT03333824.

Keyphrases

open label
clinical trial
randomized controlled trial
squamous cell carcinoma
study protocol
phase ii study
phase iii